Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18256367 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Isradipine CR 5mg;   Drug: Isradipine CR 10mg;   Drug: Isradipine CR 20mg;   Drug: Placebo

Indicates status has not been verified in more than two years